Last Price$175.8(3.8%)
Market Cap$14.5B
LTM EBITDA margin
20.2%
5Y avg
17.8%
Medical - Diagnostics & Research industry
median
(22.0%)
Stock quality & Intrinsic value
6/10
0.9% undervalued
ICON Public Limited Company EBITDA margin
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA margin | 0.0% | 13.8% | 14.0% | 15.0% | 15.9% | 14.2% | 7.3% | 10.0% | 12.6% | 17.5% | 21.5% | 22.8% | 22.9% | 17.4% | 19.0% | 17.5% | 13.5% | 18.2% | 18.7% | 19.3% |
Overvalued or undervalued?
Check the intrinsic value for ICLR
and see if it's the right time to invest.
ICON Public Limited Company (ICLR) EBITDA margin comparison analysis
General
LTM EBITDA margin
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
ICON Public Limited CompanyICLR
20.2%
2.0%
28.7%
9.6%
Median Peer Set
27.5%
1.2%
2.6%
15.6%
Waters CorporationWAT
35.0%
0.1%
(1.1%)
21.6%
IDEXX Laboratories, Inc.IDXX
32.7%
6.5%
6.1%
22.8%
Mettler-Toledo International Inc.MTD
32.2%
2.2%
12.7%
22.3%
Revvity, Inc.RVTY
31.0%
0.2%
(58.6%)
9.8%
Danaher CorporationDHR
28.3%
(0.1%)
(17.9%)
16.3%
Thermo Fisher Scientific Inc.TMO
26.7%
0.1%
6.8%
14.8%
Agilent Technologies, Inc.A
26.6%
(4.7%)
5.2%
19.8%
IQVIA Holdings Inc.IQV
22.1%
2.8%
2.4%
8.9%
Quest Diagnostics IncorporatedDGX
19.2%
6.7%
2.8%
8.8%
Natera, Inc.NTRA
(8.5%)
56.7%
(59.5%)
(11.2%)
ICLR key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 0.0 (100.0%) | 455.6 0.0% | 630.7 38.4% | 865.2 37.2% | 887.6 2.6% | 900.0 1.4% | 945.7 5.1% | 1,115.0 17.9% | 1,336.1 19.8% | 1,503.3 12.5% | 1,575.0 4.8% | 1,666.5 5.8% | 1,758.4 5.5% | 2,595.8 47.6% | 2,805.8 8.1% | 2,797.3 (0.3%) | 5,480.8 95.9% | 7,741.4 41.2% | 8,120.2 4.9% | 8,281.7 2.0% |
| Cost of Goods Sold (COGS) | 0.0 | 256.3 | 354.5 | 489.2 | 507.8 | 541.4 | 611.9 | 718.1 | 845.4 | 903.2 | 909.0 | 961.3 | 1,031.5 | 1,826.3 | 1,974.1 | 1,989.3 | 3,972.6 | 5,527.0 | 5,719.9 | 5,845.3 |
% margin | 0.0 0.0% | 199.3 43.8% | 276.2 43.8% | 376.0 43.5% | 379.8 42.8% | 358.7 39.8% | 333.8 35.3% | 396.9 35.6% | 490.6 36.7% | 600.1 39.9% | 666.0 42.3% | 705.2 42.3% | 727.0 41.3% | 769.5 29.6% | 831.7 29.6% | 808.0 28.9% | 1,508.2 27.5% | 2,214.3 28.6% | 2,400.2 29.6% | 2,436.4 29.4% |
| Operating Expenses | 0.0 | 151.5 | 207.0 | 276.5 | 272.4 | 266.6 | 294.5 | 327.3 | 360.4 | 389.0 | 384.5 | 385.3 | 395.0 | 392.4 | 398.3 | 416.1 | 900.3 | 1,348.3 | 1,444.1 | 1,338.5 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 0.0 | 136.6 | 188.0 | 248.8 | 230.9 | 232.7 | 255.9 | 280.8 | 313.9 | 336.5 | 326.8 | 325.7 | 323.7 | 325.8 | 336.7 | 341.7 | 585.3 | 778.8 | 776.4 | 728.3 |
% margin | 0.0 0.0% | 47.8 10.5% | 69.2 11.0% | 99.5 11.5% | 107.5 12.1% | 92.1 10.2% | 29.4 3.1% | 69.6 6.2% | 121.2 9.1% | 202.4 13.5% | 281.5 17.9% | 311.7 18.7% | 331.9 18.9% | 377.1 14.5% | 433.4 15.4% | 392.0 14.0% | 608.5 11.1% | 795.2 10.3% | 956.2 11.8% | 1,097.8 13.3% |
| Interest Income | 0.0 | 0.0 | 0.0 | 2.9 | 0.8 | 1.8 | 1.2 | 1.2 | 1.0 | 1.2 | 1.3 | 1.5 | 2.3 | 4.8 | 6.9 | 2.7 | 0.6 | 2.3 | 5.0 | 8.6 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 4.1 | 3.5 | 1.1 | 1.6 | 2.0 | 1.3 | 0.8 | 4.0 | 13.0 | 13.0 | 13.6 | 6.4 | 15.1 | 182.4 | 229.7 | 336.7 | 237.2 |
| Pre-tax Income | 0.0 | 51.5 | 72.0 | 98.3 | 104.7 | 92.7 | 29.0 | 68.7 | 120.9 | 202.7 | 278.9 | 300.2 | 327.7 | 368.4 | 427.0 | 382.2 | 196.7 | 567.9 | 624.5 | 869.2 |
% effective tax rate | 0.0 0.0% | 12.9 25.1% | 15.8 22.0% | 20.0 20.3% | 10.4 9.9% | 5.7 6.1% | 6.1 21.1% | 10.4 15.1% | 18.1 14.9% | 30.2 14.9% | 39.3 14.1% | 38.0 12.7% | 54.7 16.7% | 45.6 12.4% | 51.1 12.0% | 50.8 13.3% | 41.3 21.0% | 59.4 10.5% | 11.7 1.9% | 77.7 8.9% |
% margin | 0.0 0.0% | 38.3 8.4% | 56.0 8.9% | 78.1 9.0% | 94.3 10.6% | 87.1 9.7% | 22.9 2.4% | 58.3 5.2% | 102.8 7.7% | 172.5 11.5% | 239.5 15.2% | 262.2 15.7% | 272.9 15.5% | 322.8 12.4% | 374.0 13.3% | 327.8 11.7% | 153.2 2.8% | 505.3 6.5% | 612.3 7.5% | 791.5 9.6% |
| EPS | 0.00 | 1.35 | 1.95 | 1.34 | 1.61 | 1.46 | 0.38 | 0.97 | 1.69 | 2.80 | 4.08 | 4.75 | 5.04 | 5.96 | 6.94 | 6.29 | 2.28 | 6.20 | 7.46 | 9.60 |
| Diluted EPS | 0.00 | 1.33 | 1.88 | 1.30 | 1.57 | 1.44 | 0.37 | 0.96 | 1.65 | 2.73 | 3.97 | 4.65 | 4.98 | 5.90 | 6.88 | 6.24 | 2.25 | 6.13 | 7.40 | 9.53 |
% margin | 0.0 0.0% | 62.8 13.8% | 88.3 14.0% | 130.1 15.0% | 140.9 15.9% | 127.7 14.2% | 69.3 7.3% | 111.1 10.0% | 168.7 12.6% | 263.7 17.5% | 339.2 21.5% | 379.4 22.8% | 401.9 22.9% | 451.8 17.4% | 532.2 19.0% | 488.8 17.5% | 739.4 13.5% | 1,412.3 18.2% | 1,521.4 18.7% | 1,594.9 19.3% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is ICON Public Limited Company's EBITDA margin?
As of today, Microsoft Corp's last 12-month EBITDA margin is 20.2%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual EBITDA margin for ICON Public Limited Company have been 17.8% over the past three years, and 18.6% over the past five years.
2) Is ICON Public Limited Company's EBITDA margin Good?
As of today, ICON Public Limited Company's EBITDA margin is 20.2%, which is higher than industry median of (22.0%). It indicates that ICON Public Limited Company's EBITDA margin is Good.